The prospects for therapy with tumour necrosis factors and their antagonists
Trends in Biotechnology
Saved in:
Main Author: | Porter, A.G. |
---|---|
Other Authors: | INSTITUTE OF MOLECULAR & CELL BIOLOGY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/112127 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Structural and functional domains in human tumour necrosis factors
by: Goh, C.R., et al.
Published: (2014) -
Human tumour necrosis factors-α and -β: Differences in their structure, expression and biological properties
by: Porter, A.G.
Published: (2014) -
Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin)
by: Goh, C.R., et al.
Published: (2014) -
Tumour necrosis factors in clinical practice
by: Goh, C.R.
Published: (2014) -
Glycosylation and high-level secretion of human tumour necrosis factor-beta in recombinant baculovirus-infected insect cells
by: Chai, H., et al.
Published: (2014)